Skip to content
lifestyle.thenyctimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Reckitt
RECKITT ANNOUNCES U.S. FDA APPROVAL OF MUCINEX® 12HR COLD & FEVER MULTI-SYMPTOM, THE FIRST OTC INNOVATION IN THE COLD & FLU CATEGORY IN 14 YEARS
August 5, 2026
Reckitt Announces Any and All Tender Offer and Consent Solicitation for Mead Johnson Nutrition Company Notes due 2044
August 5, 2026